Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Idarucizumab 2.5 gm/50 ml vial (NDC 597019705) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 15, 2026 , from http://ppman.hank.ai/transparency/procedure/597019705/by-state?code_type=NDC
“Idarucizumab 2.5 gm/50 ml vial (NDC 597019705) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/597019705/by-state?code_type=NDC. Accessed
November 15, 2026 .
“Idarucizumab 2.5 gm/50 ml vial (NDC 597019705) by State,” HANK Price Transparency ,
accessed November 15, 2026 ,
http://ppman.hank.ai/transparency/procedure/597019705/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
597019705 — Idarucizumab 2.5 Gm/50 Ml Vial
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$2,948
National median
$2,505 – $4,289
IQR (p25 – p75)
54
hospitals filing
13
states
Walking in without insurance?
Cash / self-pay price
Cash median
$3,984
vs. negotiated
+35.1%
Hospitals reporting
76
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 597019705 (NDC), with interquartile range
State Median p25 p75
NC $542 $402 $846
CO $1,348 $1,313 $2,589
AZ $1,593 $1,463 $2,711
CA $1,593 $1,333 $3,829
OR $1,838 $1,723 $4,538
IN $2,948 $2,948 $2,948
HI $3,634 $2,987 $4,921
FL $3,910 $2,394 $6,484
OH $4,657 $3,931 $4,989
VT $5,430 $2,526 $5,812
TX $5,652 $4,945 $6,535
MD $6,369 $6,369 $6,369
NJ $19,838 $14,485 $35,111